| Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer R Rossetti, H Brand, SCG Lima, IP Furtado, RM Silveira, DMC Fantacini, ... Immunotherapy advances 2 (1), ltac005, 2022 | 14 | 2022 |
| Human and mouse melanoma cells recapitulate an EMT-like program in response to mesenchymal stromal cells secretome LEB de Souza, FU Ferreira, CH Thome, H Brand, MD Orellana, VM Faca, ... Cancer Letters 501, 114-123, 2021 | 7 | 2021 |
| Strategies to enhance the therapeutic efficacy, applicability, and safety of genetically engineered immune cells SCG de Lima, DMC Fantacini, L de Castro Batista, RM Silveira, IP Furtado, ... Critical Reviews™ in Immunology 41 (1), 2021 | 7 | 2021 |
| Metabolic and proliferation evaluation of human adipose-derived mesenchymal stromal cells (ASC) in different culture medium volumes: standardization of static culture VA Simão, CP Evangelista-Ribeiro, H Brand, L Lagass-Pereira, ... Biologicals 62, 93-101, 2019 | 7 | 2019 |
| Adipose-derived stem cells (ASCs) culture in spinner flask: improving the parameters of culture in a microcarrier-based system VA Simão, H Brand, RN da Silveira-Antunes, JT Fukasawa, J Leme, ... Biotechnology Letters 45 (7), 823-846, 2023 | 2 | 2023 |
| Generation of T lymphocytes expressing engineered T cell receptor targeting the ny-eso-1 tumor antigen using a new genetic construct R Rossetti, IP Furtado, DMC Fantacini, RM Silveira, SCG Lima, H Brand, ... Hematology, Transfusion and Cell Therapy 44, S300-S301, 2022 | 1 | 2022 |
| Evaluation of anti-CD19 CAR-T Cell persistence and efficacy using a developed multiparametric flow cytometry and qPCR tracking platform for preclinical and clinical studies LC Batista, H Brand, DMC Fantacini, DT Covas, LEB Souza Cytotherapy 23 (4), 13-14, 2021 | 1 | 2021 |
| Traditional and 3D Stem Cell Cultures Maintained in Xenobiotic-Free Conditions: Immunological Aspects ME Sakalem, H Brand, NCD dos Santos, RG de Oliveira Elsevier, 2024 | | 2024 |
| CÉLULAS T CD4 MODIFICADAS PARA EXPRESSAR CAR E RORT PRODUZEM IL-17 E IFN-E POSSUEM ATIVIDADE CITOTÓXICA CONTRA TUMORES CD19+ H Brand, LC Batista, IP Furtado, R Rossetti, RM Silveira, DMC Fantacini, ... Hematology, Transfusion and Cell Therapy 44, S644, 2022 | | 2022 |
| T CELLS ENGINEERED TO EXPRESS A CAR ANTI-GD2 AND THE COSTIMULATORY MOLECULE GITRL ERADICATE GLIOBLASTOMA CELLS AND ARE IFNY PRODUCERS IP Furtado, RM Silveira, H Brand, R Rossetti, DMC Fantacini, LEB Souza, ... Hematology, Transfusion and Cell Therapy 44, S304-S305, 2022 | | 2022 |
| UMA NOVA CONSTRUÇÃO DE CAR CONTRA O ANTÍGENO INTRACELULAR MAGE-A4 É CAPAZ DE LISAR CÉLULAS DE MIELOMA MÚLTIPLO RM Silveira, IP Furtado, H Brand, R Rossetti, DMC Fantacini, DT Covas, ... Hematology, Transfusion and Cell Therapy 44, S315, 2022 | | 2022 |
| Caracterização funcional de linfócitos T-CAR anti-CD19 polarizados para o fenótipo Th17 através da superexpressão de RORγt H Brand Universidade de São Paulo, 2022 | | 2022 |
| ANTI-CD19 CAR T CELL TRACKING PLATFORM FOR PRECLINICAL AND CLINICAL STUDIES SHOWS GREAT TUMOR BURDEN REDUCTION LINKED TO STEADY PERSISTENCE LC Batista, H Brand, DMC Fantacini, DT Covas, LEB Souza Hematology, Transfusion and Cell Therapy 43, S248, 2021 | | 2021 |
| ESTABLISHMENT OF A CRISPR/CAS9-BASED GENOME EDITING PLATFORM FOR THE GENERATION OF AN OFF-THE-SHELF ALLOGENEIC CAR-T CELL MODEL SCG Lima, H Brand, LC Batista, DMC Fantacini, MGB Coelho, FA Castro, ... Hematology, Transfusion and Cell Therapy 43, S258-S259, 2021 | | 2021 |
| POLARIZAÇÃO DE LINFÓCITOS T AO FENÓTIPO T HELPER/CITOTÓXICO 17 PARA USO EM TERAPIAS CELULARES AVANÇADAS H Brand, LC Batista, DMC Fantacini, SCG Lima, DT Covas, LEB Souza Hematology, Transfusion and Cell Therapy 43, S267, 2021 | | 2021 |
| DEVELOPMENT OF CRISPR/CAS9-BASED GENOME EDITING PLATFORM FOR THE GENERATION OF ALLOGENEIC CAR-T CELLS SCG Lima, H Brand, LC Batista, DMC Fantacini, MGB Coelho, FA Castro, ... Cytotherapy 23 (4), 10, 2021 | | 2021 |
| Optimization of a process for high-yield lentiviral vector production applied to car-t cell generation DMC Fantacini, SCG Lima, H Brand, LC Batista, R Cunha, DT Covas, ... Hematology, Transfusion and Cell Therapy 42, 421-422, 2020 | | 2020 |
| Development of a platform for tracking CAR-T cell persistence using qPCR and multiparametric flow cytometry for preclinical and clinical studies LC Batista, H Brand, DMC Fantacini, DT Covas, LEB Souza Hematology, Transfusion and Cell Therapy 42, S416-S417, 2020 | | 2020 |
| Proliferação de células-tronco derivadas de tecido adiposo humano: influência do volume de meio de cultura sobre a cinética de crescimento e parâmetros de identidade celular (2017) CPE Ribeiro, VA Simão, H Brand, LL Pereira, MSF Tsuboy, PHB Aoki, ... Resumos, 2017 | | 2017 |
